Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026)

Bausch Health Companies (BHC) reported Amortization of Deferred Charges of $14.0 million for Q1 2026, down 6.67% on a YoY basis from $15.0 million in Q1 2025, and down 36.36% sequentially from $22.0 million in Q4 2025.

Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Amortization of Deferred Charges data on file, last reported at $14.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortization of Deferred Charges fell 6.67% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2026 stood at $93.0 million (up 66.07% YoY), and the FY2025 full-year result was $94.0 million, up 70.91% from the prior year.
  • Amortization of Deferred Charges retreated to $14.0 million in Q1 2026, from $22.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $50.0 million in Q2 2022 to a low of $11.0 million in Q1 2023.
  • A 5-year average of $19.2 million and a median of $14.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
  • Across the five-year window, Amortization of Deferred Charges soared 316.67% in 2022 and sank 76.0% in 2023, its largest moves.
  • Tracing BHC's Amortization of Deferred Charges over 5 years: stood at $13.0 million in 2022, then climbed by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then jumped by 57.14% to $22.0 million in 2025, then slumped by 36.36% to $14.0 million in 2026.
  • Business Quant data shows BHC's Amortization of Deferred Charges at $14.0 million in Q1 2026, $22.0 million in Q4 2025, and $16.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.88 Bn 87.01 Bn -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn
3 Zoetis 32.31 Bn 30.37 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn -
7 Viatris 20.27 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.92 Bn 16.61 Bn 800.70 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn
10 Bausch Health Companies 1.68 Bn 365.34 Mn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.00 Mn
Mar 31, 2026 14.00 Mn
Dec 31, 2025 22.00 Mn
Dec 31, 2025 22.00 Mn
Sep 30, 2025 16.00 Mn
Sep 30, 2025 16.00 Mn
Jun 30, 2025 41.00 Mn
Jun 30, 2025 41.00 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 14.00 Mn
Dec 31, 2024 14.00 Mn
Sep 30, 2024 13.00 Mn
Sep 30, 2024 13.00 Mn
Jun 30, 2024 14.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 14.00 Mn
Dec 31, 2023 14.00 Mn